The study by Goldberg and colleagues [3] demonstrated that collaboration of an IDH2 mutation with a NUP98-HOXD13 translocation leads to a highly penetrant EITP-ALL by targeting early thymic progenitor cells. The gene discussed is IDH2; the disease is acute lymphoblastic leukemia.